i'm saying that if we develop a biomarker that is identifying the earliest footprints of pancreatic cancer we put that next in the next lane and for ovarian cancer in the next or for each cancer we develop like a bar code and with one drop of blood so toshiba a company just announced that they can detect 13 different cancers from one drop of blood in four hours for 180 dollars there's a company in the bay area that i follow very closely called grail and they're doing something very similar at this point they're you know in phase 2 with probably almost 30 different cancers